Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation

International Immunopharmacology

Volumn 5, Issue 1, 2005, Pages 107-115

  Kornberg, A ^a   Kupper B ^a   Tannapfel, A ^b   Hommann, M ^a   Scheele, J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Fibrosis; Hepatitis C; Immunosuppression; Interferon 2b ribavirin; Mycophenolate mofetil

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; CELL CEPT; CYCLOSPORIN A; DACLIZUMAB; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROSIS; FOLLOW UP; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AZATHIOPRINE; CYCLOSPORINE; FEMALE; FIBROSIS; GRAFT REJECTION; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 10344243982     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.09.010     Document Type: Article

References (33)

1. L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, and M.R. Lucey The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
2. E. Gane The natural history and outcome of liver transplantation in hepatitis C-virus infected recipients Liver Transpl. 9 2003 28 34
3. K.V. Narayanan Menon, J.J. Poterucha, O.M. El Amin, L.J. Burgart, W.K. Kremers, and B. Rosen Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy Liver Transpl. 8 2002 623 629
4. D. Samuel, T. Bizollon, C. Feray, B. Roche, S.N. Ahmed, and C. Lemonnier Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642 650
5. M. Berenguer, M. Prieto, J.M. Rayon, J. Mora, M. Pastor, and V. Ortiz Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation Hepatology 32 2000 852 858
6. M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim, and M. Rayon HCV-related fibrosis progression following liver transplantation: increase in recent years J. Hepatol. 32 2000 673 684
7. M. Berenguer, M. Prieto, J. Cordoba, J.M. Rayon, D. Carasco, and V. Olaso Early development of chronic active hepatitis in recurrent hepatitis C after liver transplantation: association with treatment of rejection J. Hepatol. 28 1998 756 763
8. R. Pfitzmann, J. Klupp, J.M. Langrehr, M. Uhl, R. Neuhaus, and U. Settmacher Mycophenolate mofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients Transplantation 76 2003 130 136
9. J. Neyts, A. Meerbach, P. McKenna, and E. De Clercq Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections Antivir. Res. 30 1996 125 132
10. K.P. Platz, A.R. Mueller, C. Willimski, B. Mansoorian, T. Berg, and R. Neuhaus Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation Transplant. Proc. 30 1998 2232 2233
11. A. Jain, R. Kashyap, A.J. Demetris, B. Eghstesad, R. Pokharna, and J.J. Fung A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C Liver Transpl. 8 2002 40 46
12. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J. Hepatol. 22 1995 696 699
13. R.G. Knodell, K.G. Ishak, W.C. Black, T.S. Chen, R. Craig, and N. Kaplowitz Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
14. G.T. Everson Impact of immunosuppressive therapy on recurrence of hepatitis C Liver Transpl. 8 2002 19 27
15. P.A. Sheiner, M.E. Schwartz, E. Mor, L.K. Schluger, N. Theise, and K. Kishikawa Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation Hepatology 21 1995 30 34
16. H.R. Rosen, C.R. Shackleton, L. Higa, I.M. Gralnek, D.A. Farmer, and S.V. McDiarmid Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am. J. Gastroenterol. 92 1997 1453 1457
17. A. Kornberg, M. Hommann, A. Tannapfel, T. Wagner, T. Grube, and U. Schotte Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients Am. J. Transplant. 1 2001 350 355
18. R.H. Weisner, J. Rabkin, G. Klintmalm, S. McDiarmid, A. Langnas, and J. Punch A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosprine and corticosteroids in primary liver transplant recipients Liver Transpl. 7 2001 442 450
19. A.C. Allison, and E.M. Eugui Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) Clin. Transplant. 10 1996 77 84
20. J.L. Patterson, and R. Fernandez-Larsson Molecular mechanisms of action of ribavirin Rev. Infect. Dis. 12 1990 1139 1146
21. L. Rostaing, J. Izopet, K. Sandres, J.M. Cisterne, J. Puel, and D. Durand Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil Transplantation 69 2000 991 994
22. J.P. Ong, D.S. Barnes, Z.M. Younossi, T. Gramlich, B. Yen-Lieberman, and M. Goormastic Outcome of de novo hepatitis C virus infection in heart transplant recipients Hepatology 30 1999 1293 1298
23. G.A. Smallwood, L. Davis, E. Martinez, A.C. Stieber, and T.G. Heffron Mycophenolate's influence in the treatment of recurrent hepatitis c following liver transplantation Transplant. Proc. 34 2002 1559 1560
24. M.E. de Vera, G.A. Smallwood, K. Rosado, L. Davis, E. Martinez, and S. Sharma Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation Transplantation 71 2001 678 686
25. S. Saab, R. Hu, A.B. Ibrahim, L.I. Goldstein, G. Kunder, and F. Durazo Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C Am. J. Transplant. 3 2003 28 33
26. M. Berenguer, M. Prieto, A. Palau, J.M. Rayon, D. Carrasco, and F. San Juan Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis Liver Transpl. 9 2003 228 235
27. A.L. Doughty, J.D. Spencer, Y.E. Cossart, and G.W. McCaughan Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels Liver Transplant. Surg. 4 1998 15 21
28. O. Alonso, C. Loinaz, M. Abradelo, B. Perez, A. Manrique, and R. Gómez Changes in the incidence and severity of recurrent hepatitis C after liver transplantation over 1990-1999 Transplant. Proc. 5 2003 1836 1837
29. G.V. Papatheodoridis, S. Davies, A.P. Dhillon, R. Teixeira, J. Goulis, and B. Davidson The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 72 2001 412 418
30. T.N.G. Kato, M. Montalbano, O. Hugo, R. Lavendera, D. Wendler, and D.M. Levi Steroid-free induction with tacrolimus and daclizumab in liver transplant recipients with hepatitis C-A preliminary report of a prospective randomized trial [abstract 173] Am. J. Transplant. 1 2001 179
31. D.R. Nelson, C. Soldevila-Pico, A. Reed, M.F. Abdelmalek, A.W. Hemming, and W.J. Van der Werf Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C: a multicenter trial Hematology 26 1997 473 477
32. H.R. Rosen, D.J. Hinrichs, D.R. Gretch, M.J. Koziel, S. Chou, and M. Houghton Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation Gastroenterology 117 1999 926 932
33. R. Firpi, D. Nelson, and G. Davis Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection Liver Transplant. 9 2003 57 62